Jennifer H. Choe

1.6k total citations
23 papers, 158 citations indexed

About

Jennifer H. Choe is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Jennifer H. Choe has authored 23 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Surgery and 4 papers in Otorhinolaryngology. Recurrent topics in Jennifer H. Choe's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Head and Neck Cancer Studies (4 papers). Jennifer H. Choe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Head and Neck Cancer Studies (4 papers). Jennifer H. Choe collaborates with scholars based in United States, Australia and United Kingdom. Jennifer H. Choe's co-authors include Gerald S. Falchook, Michelle Ferreira, Charles G. Drake, Emerson A. Lim, Gayle P. Pouliot, Kris F. Sachsenmeier, Janet L. Karlix, Todd M. Bauer, Johanna C. Bendell and Daniel J. George and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and Clinical Cancer Research.

In The Last Decade

Jennifer H. Choe

22 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer H. Choe United States 6 88 46 41 35 24 23 158
Nicolas Gourdin France 4 95 1.1× 32 0.7× 99 2.4× 46 1.3× 6 0.3× 6 158
Jacqueline H. Starrett United States 4 95 1.1× 41 0.9× 28 0.7× 21 0.6× 73 3.0× 5 136
Ryan C. Augustin United States 6 153 1.7× 125 2.7× 114 2.8× 50 1.4× 28 1.2× 15 300
Hanshen Yang China 9 130 1.5× 111 2.4× 91 2.2× 8 0.2× 30 1.3× 16 244
Nicole Milenkovski Canada 4 239 2.7× 79 1.7× 197 4.8× 154 4.4× 20 0.8× 4 368
Dalia K. Omran United States 7 112 1.3× 48 1.0× 62 1.5× 4 0.1× 11 0.5× 8 158
Minomi Subapanditha Canada 7 70 0.8× 76 1.7× 12 0.3× 5 0.1× 24 1.0× 14 153
R Facchini United Kingdom 4 31 0.4× 31 0.7× 45 1.1× 10 0.3× 9 0.4× 5 106
Yixuan Guo China 5 67 0.8× 61 1.3× 86 2.1× 4 0.1× 35 1.5× 11 206
M. Jevric Serbia 5 48 0.5× 40 0.9× 23 0.6× 3 0.1× 16 0.7× 12 111

Countries citing papers authored by Jennifer H. Choe

Since Specialization
Citations

This map shows the geographic impact of Jennifer H. Choe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer H. Choe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer H. Choe more than expected).

Fields of papers citing papers by Jennifer H. Choe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer H. Choe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer H. Choe. The network helps show where Jennifer H. Choe may publish in the future.

Co-authorship network of co-authors of Jennifer H. Choe

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer H. Choe. A scholar is included among the top collaborators of Jennifer H. Choe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer H. Choe. Jennifer H. Choe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choe, Jennifer H., et al.. (2025). Metastatic Head and Neck Cancer: Immunotherapy and Beyond. Seminars in Radiation Oncology. 35(2). 259–270. 2 indexed citations
2.
Keulen, Stan van, Hidenori Tanaka, Michael C. Topf, et al.. (2025). Fluorescence-Guided Surgery for Assessing Margins in Head and Neck Cancer. JAMA Surgery. 160(9). 1018–1018.
3.
Rischin, Danny, David Miller, Nikhil I. Khushalani, et al.. (2024). 1091P Neoadjuvant cemiplimab for stage II–IV cutaneous squamous cell carcinoma (CSCC): 2-year follow-up and biomarker analyses. Annals of Oncology. 35. S722–S722. 2 indexed citations
4.
Choe, Jennifer H., et al.. (2024). Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances. Current Oncology Reports. 26(9). 1120–1133. 3 indexed citations
5.
Choe, Jennifer H., et al.. (2024). Immunotherapy in Head and Neck Cancer. Surgical Oncology Clinics of North America. 33(4). 605–615. 4 indexed citations
6.
7.
Gianoukakis, Andrew G., Jennifer H. Choe, Daniel W. Bowles, et al.. (2023). Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer. European Thyroid Journal. 13(1). 3 indexed citations
8.
Lim, Emerson A., Johanna C. Bendell, Gerald S. Falchook, et al.. (2022). Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors. Clinical Cancer Research. 28(22). 4871–4884. 55 indexed citations
9.
Akce, Mehmet, Siwen Hu‐Lieskovan, Matthew J. Reilley, et al.. (2022). A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3).. Journal of Clinical Oncology. 40(16_suppl). 2604–2604. 8 indexed citations
10.
Choe, Jennifer H., et al.. (2022). Zimberelimab. Anti-programmed cell death protein 1 (PD-1) monoclonal antibody, Treatment of Hodgkin lymphoma, Treatment of advanced solid tumors. Drugs of the Future. 47(2). 115–121. 1 indexed citations
11.
Sag, Alan A., Jennifer M. Perkins, Hadiza S. Kazaure, et al.. (2022). Salvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures. Journal of Vascular and Interventional Radiology. 34(1). 54–62. 3 indexed citations
12.
Gross, Neil D., David Miller, Emily S. Ruiz, et al.. (2022). 789O Neoadjuvant cemiplimab in patients (pts) with stage II–IV (M0) cutaneous squamous cell carcinoma (CSCC): Primary analysis of a phase II study. Annals of Oncology. 33. S904–S905. 2 indexed citations
13.
Mowery, Yvonne M., Donna Niedzwiecki, Jennifer H. Choe, David G. Kirsch, & David M. Brizel. (2022). Phase I trial of the ATR inhibitor BAY 1895344 combined with stereotactic body radiation therapy and pembrolizumab for recurrent head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 40(16_suppl). TPS6108–TPS6108. 4 indexed citations
14.
Ferreira, Michelle & Jennifer H. Choe. (2021). Guiding immunotherapy combinations: Who gets what?. Advanced Drug Delivery Reviews. 178. 113962–113962. 9 indexed citations
15.
Grover, Punita, Joanne Xiu, Chadi Nabhan, et al.. (2021). Comprehensive genomic profiling and immune characterization of adenoid cystic carcinoma.. Journal of Clinical Oncology. 39(15_suppl). e18050–e18050. 1 indexed citations
16.
Sag, Alan A., Hadiza S. Kazaure, Jennifer M. Perkins, et al.. (2020). Clinical Image-Guided Ablation for Thyroid Malignancy with Proposed Thyroid Segmentation System. 2. 139–150. 1 indexed citations
17.
Siu, Lillian L., Joshua Bauml, Douglas Adkins, et al.. (2019). Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC).. Journal of Clinical Oncology. 37(15_suppl). TPS6092–TPS6092. 3 indexed citations
18.
Eng, Cathy, Jennifer H. Choe, Michael J. Overman, et al.. (2013). Assessment of the impact of systemic chemotherapy (SC) on the quality of life (QOL) in patients with metastatic unresectable appendiceal epithelial neoplasms (AEN).. Journal of Clinical Oncology. 31(4_suppl). 522–522. 1 indexed citations
19.
Hong, David S., Jennifer H. Choe, Aung Naing, et al.. (2012). A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors. Investigational New Drugs. 31(4). 918–926. 22 indexed citations
20.
Choe, Jennifer H.. (2011). Altered Responses to Endoplasmic Reticulum Stress in Pancreatic Cancer. Digital Commons-TMC (Texas Medical Center). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Gourdin Breakdown of academic impact, for papers by Jacqueline H. Starrett Breakdown of academic impact, for papers by Ryan C. Augustin Breakdown of academic impact, for papers by Hanshen Yang Breakdown of academic impact, for papers by Nicole Milenkovski Breakdown of academic impact, for papers by Dalia K. Omran Breakdown of academic impact, for papers by Minomi Subapanditha Breakdown of academic impact, for papers by R Facchini Breakdown of academic impact, for papers by Yixuan Guo Breakdown of academic impact, for papers by M. Jevric
Rankless by CCL
2026